Commonwealth Equity Services
EBS icon

Commonwealth Equity Services’s Emergent Biosolutions EBS Stock Holding History

Commonwealth Equity Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,117
Closed -$151K – 4333
2025
Q3 		$151K Buy
17,117
+4,823
+39% +$37.5K ﹤0.01% 4017
2025
Q2 		$78K Buy
+12,294
New +$70.4K ﹤0.01% 4100
2021
Q4 		– Sell
-8,332
Closed -$417K – 3674
2021
Q3 		$417K Sell
8,332
-4,072
-33% -$247K ﹤0.01% 2615
2021
Q2 		$781K Sell
12,404
-807
-6% -$51.8K ﹤0.01% 2105
2021
Q1 		$1.23M Sell
13,211
-799
-6% -$81.8K ﹤0.01% 1652
2020
Q4 		$1.25M Buy
14,010
+2,454
+21% +$225K ﹤0.01% 1518
2020
Q3 		$1.19M Buy
11,556
+1,724
+18% +$186K ﹤0.01% 1389
2020
Q2 		$777K Buy
9,832
+1,155
+13% +$86.1K ﹤0.01% 1581
2020
Q1 		$502K Buy
8,677
+775
+10% +$44.7K ﹤0.01% 1685
2019
Q4 		$426K Buy
+7,902
New +$429K ﹤0.01% 2034

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commonwealth Equity Services's EBS Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 17,117 shares — an estimated $151K sold.

Commonwealth Equity Services first reported a position in EBS in Q4 2019 and held it in 10 quarters. The position peaked at $1.25M in Q4 2020. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Commonwealth Equity Services reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 17,117 Emergent Biosolutions shares in Q4 2025, an estimated $151K.
  • Commonwealth Equity Services first reported a position in Emergent Biosolutions in Q4 2019 and held it in 10 quarters.
  • Commonwealth Equity Services's Emergent Biosolutions position peaked at $1.25M in Q4 2020.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.